Suchergebnisse - (Subject:"ritonavir")

PubPharm (49)

21

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2) : two multicentre, double-blind, randomised controlled trials

enthalten in: Lancet (London, England) | 2010

von Eron, J. | Young, B. | Cooper, D. | +108

CommentIn: Lancet. 2010 Jan 30;375(9712):352-4. - PMID 20074790

22

A king in the CASTLE? Optimum initial HIV protease inhibitor

enthalten in: Lancet (London, England) | 2008

von Torti, C. | Frank, I.

CommentOn: Lancet. 2008 Aug 23;372(9639):646-55. - PMID 18722869

23

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients : 48 week efficacy and safety results of the CASTLE study

enthalten in: Lancet (London, England) | 2008

von Molina, J. | Andrade-Villanueva, J. | Echevarria, J. | +110

CommentIn: Lancet. 2008 Aug 23;372(9639):604-6. - PMID 18722849

24

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN : a randomised controlled phase III trial

enthalten in: Lancet (London, England) | 2007

von Madruga, J. | Berger, D. | McMurchie, M. | +11

CommentIn: Lancet. 2007 Jul 7;370(9581):3-5. - PMID 17617250

25

Improving access to second-line antiretrovirals

enthalten in: Lancet (London, England) | 2007

von The Lancet

26

Darunavir : promising initial results

enthalten in: Lancet (London, England) | 2007

von MacArthur, R.

CommentOn: Lancet. 2007 Apr 7;369(9568):1169-78. - PMID 17416261

27

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2 : a pooled subgroup analysis of data from two randomised trials

enthalten in: Lancet (London, England) | 2007

von Clotet, B. | Bellos, N. | Molina, J. | +15

ErratumIn: Lancet. 2008 Jan 12;371(9607):116

28

Chaperonin 10 for rheumatoid arthritis

enthalten in: Lancet (London, England) | 2006

von Kast, R. | Altschuler, E.

CommentOn: Lancet. 2006 Sep 2;368(9538):855-63. - PMID 16950363

29

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks : a randomised non-inferiority trial

enthalten in: Lancet (London, England) | 2006

von Eron, J. | Yeni, P. | Gathe, J. | +14

ErratumIn: Lancet. 2006 Oct 7;368(9543):1238

30

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies : an analysis of combined data from two randomised open-label trials

enthalten in: Lancet (London, England) | 2006

von Hicks, C. | Cahn, P. | Cooper, D. | +9